---
figid: PMC5931274__f1000research-7-14391-g0000
figlink: /pmc/articles/PMC5931274/figure/f1/
number: Figure 1.
caption: The figure shows the RAF-MEK-ERK signaling pathway in hairy cell leukemia
  and highlights targets for therapeutic intervention.
pmcid: PMC5931274
papertitle: Recent advances in understanding and managing hairy cell leukemia.
reftext: Tobias Roider, et al. F1000Res. 2018;7:F1000 Faculty Rev-509.
pmc_ranked_result_index: '19576'
pathway_score: 0.930222
filename: f1000research-7-14391-g0000.jpg
figtitle: RAF-MEK-ERK signaling pathway in hairy cell leukemia
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5931274__f1000research-7-14391-g0000.html
  '@type': Dataset
  description: The figure shows the RAF-MEK-ERK signaling pathway in hairy cell leukemia
    and highlights targets for therapeutic intervention.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - ARAF
  - BRAF
  - HRAS
  - MAP2K1
  - RAF1
  - KRAS
  - MAP2K2
  - MAPK3
  - MAPK1
  - Vemurafenib
  - Dabrafenib
  - Selumetinib
  - Trametinib
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: BRAF-
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Trametinib
  source: MESH
  identifier: C560077
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
